IP Library Granted Patent US 7,723,571
Granted Patent B2
US 7,723,571 · App. 11/810,863 · Granted May 25, 2010

Method of expressing small peptides using cereal non-storage proteins as fusion carrier in endosperm and the use thereof

Assignee: Healthgen Biotechnology Inc. in Wuhan
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,723,571
App. No.
11/810,863
Granted
May 25, 2010
Kind
B2
Abstract

The present invention provides a method of using cereal non-storage protein as fusion carrier to highly express small peptides in host endosperm cells. The method includes the steps of providing an endosperm-specific promoter and a DNA leading sequence encoding an endosperm-specific signal peptide; providing the gene of a non-storage protein as fusion carrier and an target gene; constructing a expression vector containing the promoter and DNA leading sequence, the gene of the fusion carrier, and a target gene; and expressing the expression vector in a host endosperm cell. Also provided in the invention are a vector constructed there from and the use thereof.

Claims (21)

1. A method of expressing a small peptide in host endosperm cells, comprising the steps of:

(i) providing an endosperm-specific promoter and a DNA leading sequence encoding an endosperm-specific signal peptide;

(ii) providing a polynucleotide encoding a peptide consisting of a C terminus end of protein disulfide bond dismutase (PDI) as fusion carrier, wherein said C-terminus end possesses molecular chaperone activity;

(iii) providing a target nucleic acid encoding the small peptide, wherein the small peptide is between 20 and 100 amino acids in length;

(iv) constructing an expression vector comprising the promoter, the DNA leading sequence, the polynucleotide encoding the fusion carrier and the target nucleic acid encoding the small peptide wherein the target nucleic acid encoding the small peptide is fused to the 3′ end of the polynucleotide encoding the fusion carrier, wherein a fusion protein expressed from said expression vector comprises the small peptide fused to the C-terminus of said fusion carrier;

(v) transforming a plant cell with the expression vector; and

(vi) regenerating a mature plant from the transformed cell, such that seeds comprising endosperm cells are produced in which the peptide is expressed.

2. The method of claim 1 , further comprising the step of optimizing at least one of DNA leading sequence, the polynucleotide encoding the fusion carrier, and the target nucleic acid encoding the small peptide such that the coding sequence comprises codons preferred by the host, before the step of constructing the expression vector.

3. The method of claim 1 , further comprising the step of introducing a selectable marker into the expression vector.

4. The method of claim 1 , wherein the endosperm-specific promoter and DNA leading sequence are from Gt13a gene; the host is rice, wheat or barley; the C terminus of PDI is from rice, wheat or barley; and the target nucleic acid encoding the small peptide is DNA encoding a therapeutic peptide.

5. The method of claim 4 , wherein the host is rice and the therapeutic peptide is human IGF-1.

6. The method of claim 4 , wherein the host is barley and the therapeutic peptide is human IGF-1.

7. The method of claim 1 , wherein the C terminus of PDI from rice, wheat, or barley comprises an amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 4.

8. A method of expressing IGF-1 peptide in host endosperm cells, comprising the steps of:

(i) providing an endosperm-specific promoter and a DNA leading sequence encoding an endosperm-specific signal peptide;

(ii) providing a polynucleotide encoding the C terminus end of protein disulfide bond dismutase (PDI) as fusion carrier, wherein said C-terminus end of PDI possesses molecular chaperone activity;

(iii) providing a nucleic acid encoding IGF-1;

(iv) constructing an expression vector comprising the promoter, the DNA leading sequence, the polynucleotide encoding the C-terminus end of PDI and the nucleic acid encoding IGF-1, wherein the nucleic acid encoding IGF-1 is fused to the 3′ end of the polynucleotide encoding PDI, wherein a fusion protein expressed from said expression vector comprises IGF-1 peptide fused to the C-terminus of PDI;

(v) transforming a plant cell with the expression vector; and

(vi) regenerating a mature plant from the transformed cell, such that seeds comprising endosperm cells are produced in which the peptide is expressed.

9. The method of claim 8 , wherein the polynucleotide encoding the C-terminus end of PDI is SEQ ID NO: 4.

Assignments (2)
CHANGE OF NAME AND ADDRESS OF ASSIGNEE Recorded May 7, 2015
From: HEALTHGEN BIOTECHNOLOGY INC. IN WUHAN
To: WUHAN HEALTHGEN BIOTECHNOLOGY CORP.
Reel/Frame 035615/0734 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2007
From: YANG, DAICHANG; XIE, TINGTING
To: HEALTHGEN BIOTECHNOLOGY INC. IN WUHAN
Reel/Frame 019479/0803 →
Priority Claims (1)
CN 2006 1 0019285 · Jun 8, 2006 · national
Continuity (1)
Related Publication 20070289033A1 · Dec 13, 2007